Back to Search Start Over

Learning From Trials: Time to Look More Closely at the Kidneys in ATTR Amyloidosis?

Authors :
Obici L
Mussinelli R
Palladini G
Source :
JACC. CardioOncology [JACC CardioOncol] 2024 Apr 16; Vol. 6 (2), pp. 307-309. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Publication Year :
2024

Abstract

Competing Interests: Dr Obici has received speaker and/or consulting honoraria from Alnylam, AstraZeneca, BridgeBio, Intellia, Novo Nordisk, Pfizer, and SOBI. Dr Mussinelli has received speaker honoraria from Pfizer and SOBI. Dr Palladini has received speaker and/or consulting honoraria from Alexion, Glaxo Smith Kline, Janssen, Life Molecular Imaging, Pfizer, and Protego.

Details

Language :
English
ISSN :
2666-0873
Volume :
6
Issue :
2
Database :
MEDLINE
Journal :
JACC. CardioOncology
Publication Type :
Editorial & Opinion
Accession number :
38774011
Full Text :
https://doi.org/10.1016/j.jaccao.2024.03.004